The subject of the contract is the supply of medicinal products, chemotherapy drugs, drugs under the RDTL, foodstuffs for special medical purposes and dressings for patients with EB. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the SWZ. The Contracting Authority declares that being the data controller and taking into account the provisions of the Act of 10.5.2018 on the Protection of Personal Data (hereinafter referred to as GDPR), it has implemented security measures adequate to the risks identified by it and providing a guarantee of proper protection of personal data transferred as part of the procedure. A detailed information clause in Article 13 of the GDPR is contained in

in SWZ. Order. does not require a deposit. Order. does not provide for the possibility of awarding contracts referred to in Article 214 paragraph 1 point 8.The contracting authority does not provide for an on-site inspection. Order. provides for the application of the so-called reverse procedure referred to in Article 139(1) of the PPL.

Part 1 - Medicinal product. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part 10 - Medicinal product. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 11 - Medicinal products. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part 12 - Medicinal products. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 13 - Medicinal products - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 14 - Medicinal product - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 15 - Medicinal product - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 16 - Medicinal products - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 17 - Medicinal products - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 18 - Medicinal products - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 19 - Medicinal product - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 2 - Medicinal product. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 20 - Medicinal products - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 21 - Medicinal product - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 22 - Medicinal products - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 23 - Medicinal products - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 24 - Medicinal product - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Lot No. 25 - Medicinal product - under the RDTL. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 26 - Preparation for painless removal of adhesives for patients with epidermolysis bullosa. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 27 - Bandages to support dressings for use in patients with epidermolysis bullosa (EB) . A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 28 - Products for the treatment of acute and chronic wounds in patients with epidermolysis bullosa (EB). A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 29 - Products for the treatment of acute and chronic wounds in patients with epidermolysis bullosa (EB). A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part 3 - Medicinal products. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No 30 - Medicinal products . A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part 4 - Medicinal product. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part 5 - Medicinal product. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part 6 - Medicinal products. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No 7 - Medicinal product. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part No. 8 - Dietary products for particular nutritional uses. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to the Terms of Reference.1.The Contracting Authority requires that the following means of evidence be submitted together with the offer, under pain of nullity, in electronic form to confirm that the offered supplies meet the requirements specified by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.

Part 9 - Medicinal products. A detailed description and method of order execution can be found in the assortment and price table Appendix. No. 2 to the Terms of Reference and a model agreement Appendix. No. 4 to SWZ.1.

The Contracting Authority shall request the submission with the tender under the rigour of annulment in electronic form of the following measures of evidence in question to confirm that the deliveries offered meet the requirements laid down by the Contracting Authority:

1) a statement that the drug submitted in the offer has valid marketing authorisation documents - for lots no. 1-25, 30;

2) information materials containing a description of the offered subject of the contract (prospectus, catalogue, card, technical data form, etc.), confirming the requirements contained in Appendix No. 2 to the Terms of Reference (with the indication of the required parameters, the position of the offered subject of the contract) - regarding lots No. 26-29;

3)a valid document confirming approval for marketing and use as a medical device meeting the requirements within the meaning of the Act of 07 April 2022 on medical devices (i.e. Journal of Laws of 2022, item 974), i.e. a declaration of conformity (issued by the manufacturer or an authorized (authorized) representative) and a certificate of a notified body (identifying the manufacturer and type of device), if the assessment was carried out with the participation of a notified body (if an assessment was required Notified Body) - for Lots No. 26-29.

2.If the Contractor does not submit the measures of evidence in question or the measures in question are incomplete, the Contracting Authority shall call for their submission or supplement within the time limit set.